Case of chilblain lupus triggered by adalimumab therapy in a patient with psoriasis.

Semiz, Yavuz; Yildirim Bay, Esra; Oguz Topal, Ilteris; Yalçin, Özben

Semiz, Yavuz; Yildirim Bay, Esra; Oguz Topal, Ilteris; Yalçin, Özben.

Affiliation

Semiz Y; Department of Dermatology, Prof Dr Cemil Tasçioglu City Hospital (Okmeydani Training and Research Hospital), Istanbul, Turkey.
Yildirim Bay E; Department of Dermatology, Prof Dr Cemil Tasçioglu City Hospital (Okmeydani Training and Research Hospital), Istanbul, Turkey.
Oguz Topal I; Department of Dermatology, Prof Dr Cemil Tasçioglu City Hospital (Okmeydani Training and Research Hospital), Istanbul, Turkey.
Yalçin Ö; Department of Pathology, Prof Dr Cemil Tasçioglu City Hospital (Okmeydani Training and Research Hospital), Istanbul, Turkey.

J Cosmet Dermatol ; 21(9): 4089-4090, 2022 09.

Article de En | MEDLINE | ID: mdl-34971488

Sujet(s)
Mots clés

TNF-α inhibitors; adalimumab; adverse event; chilblain lupus; psoriasis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Psoriasis / Lupus érythémateux cutané / Érythème pernio Type d'étude: Diagnostic_studies Limites: Humans Langue: En Journal: J Cosmet Dermatol Sujet du journal: DERMATOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google